Rotavac 5D Oral Vaccine
Rotavac 5D Oral Vaccine is a live attenuated oral vaccine used for the prevention of rotavirus gastroenteritis in infants. It contains a weakened form of rotavirus (100,000 IU), which stimulates the immune system to protect against future infections. It is developed and marketed by Bharat Biotech and administered orally under medical supervision.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Live attenuated rotavirus strain (100,000 IU)
-
Oral administration, needle-free
-
Developed using Indian neonatal rotavirus 116E strain
-
Stable at 2–8°C, enabling easy storage and distribution
-
WHO-prequalified for use in global immunization programs
-
Suitable for use in infants from 6 to 32 weeks of age
| Technical Specification |
|
|---|
- 0.5 ml PFS
-
Effectively prevents severe diarrhea and dehydration caused by rotavirus
-
Oral delivery – safe and painless for infants
-
Reduces hospitalization and mortality due to rotavirus infections
-
Can be integrated into routine immunization programs
-
Thermostable formulation supports vaccine access in rural areas
-
Developed from a locally isolated strain – high efficacy in Indian population
